Introduction {#s01}
============

Professional phagocytes clear apoptotic cells and cellular debris both at baseline and during pathology, maintaining tissue homeostasis and preventing inflammation ([@bib60]; [@bib4]). The professional phagocytes in the central nervous system (CNS) are microglia, which are capable of responding rapidly to tissue damage by extending cell processes, engulfing debris, and undergoing proliferation ([@bib19]; [@bib49]; [@bib1]; [@bib52]; [@bib67]; [@bib15]). Microglia were also shown to play a major role in CNS development through their engulfment of superfluous neuronal (presynaptic) material ([@bib62]; [@bib53]; [@bib8]; [@bib13]). Specifically, neuronal activity and the complement system were shown to regulate microglial engulfment of presynaptic terminals, thus ensuring optimal architecture of the visual system. Despite those important findings, our understanding of microglial phagocytic activity in adulthood is still limited. Up to now, researchers have studied microglial phagocytosis in adulthood mainly by using exogenous phagocytic targets, such as cells killed ex vivo or various types of beads. Such targets are usually delivered by their direct injection into the CNS, disrupting the blood--brain barrier, which results in parenchymal injury, peripheral monocyte engraftment ([@bib44]), complement and IgG deposition, and activation of microglia ([@bib50]). Documentation of microglial clearance of neuronal and myelin debris has been well characterized previously, with a heavy emphasis placed on cuprizone models of demyelination and spinal cord injury ([@bib59]; [@bib28]; [@bib29]). Further, the phagocytic receptor TREM2 was shown to be critical for efficient removal of myelin debris after cuprizone-mediated demyelination ([@bib51]). Although these models show robust roles for microglial clearance of debris, they are limited as a result of the potential contribution of peripheral myeloid cells in these models ([@bib28]; [@bib39]).

Our laboratory and others have used crush injury of the optic nerve as a model to study neurodegeneration and neuroprotection, in both of which the immune system is a key player ([@bib48]; [@bib56]; [@bib55]; [@bib45]; [@bib71], [@bib72]; [@bib23]; [@bib6]). Over several weeks after the injury, there is a gradual decline in the population of retinal ganglion cells (RGCs) that innervate the superior colliculus, the suprachiasmatic nucleus of the hypothalamus, and the lateral geniculate nucleus (LGN) of the thalamus. Concurrently, the distal stump of the nerve and projections from the RGCs succumb to Wallerian degeneration ([@bib41]; [@bib69]). Within the LGN, experiments using transmission electron microscopy have shown that optic nerve injury is followed by rapid degeneration of retinogeniculate terminals, where presynaptic debris is observed within activated glial cells ([@bib68]; [@bib24]; [@bib73]). Accordingly, we postulated that after an optic nerve crush injury in the adult mouse, LGN microglia become activated and engulf synaptic material, a process similar to that seen in the developing animal during refinement of the binocular architecture of the dorsal lateral geniculate nucleus (dLGN; [@bib53]). With this system established, we could then proceed to assess microglial engulfment of endogenous debris, without introduction of exogenous material or breach of the blood--brain barrier.

Here, we show that after optic nerve crush injury, during Wallerian degeneration of retinogeniculate inputs, microglia serve as key players in clearance of the resulting presynaptic debris. We found that resident dLGN microglia exhibit a dynamic transcriptional signature after injury (up-regulating C1q and CD11b, both shown to be necessary for debris clearance in development; [@bib62]; [@bib53]) and that microglial depletion causes neuronal debris to accumulate. We also observed that postinjury activation of microglia and phagocytosis are regulated by synaptic integrity rather than by neuronal activity, a finding that distinguishes microglial function in neurodegeneration from that seen in development.

Results and discussion {#s02}
======================

Microglia are activated after optic nerve crush injury and phagocytose neuronal debris {#s03}
--------------------------------------------------------------------------------------

We first assessed the function and kinetics of dLGN microglia in response to neurodegeneration. To this end, we injected the right eyes of WT mice with cholera toxin subunit B (CTB) conjugated to Alexa Fluor 647, 24 h before subjecting the mice to crush injury ([@bib55]; [Fig. 1 A](#fig1){ref-type="fig"}). After the injury, mice were killed at various time points (days 1--5, 7, and 28 after crush). Measurement of CTB-tagged retinogeniculate inputs into the dLGN, contralateral to the injected eye, revealed their progressive loss with substantial loss observed on day 3 and an even greater loss (∼70%) on day 7 after the crush injury ([Fig. 1, B and C](#fig1){ref-type="fig"}). By day 28, no CTB-647 signal could be detected ([Fig. 1, B and C](#fig1){ref-type="fig"}). We observed an increase in the numbers of Iba1+ cells in the dLGN, starting on day 2 after the crush injury and peaking on day 7 ([Fig. 1, B and D](#fig1){ref-type="fig"}), similar to what has been previously seen in nerve injury models ([@bib5]; [@bib65]). Ki67+ (proliferating) microglia were detectable by postinjury day 2, with a significant increase in their numbers on days 3 and 4, followed by a marked reduction on day 5 ([Fig. 1, B and E](#fig1){ref-type="fig"}).

![**Optic nerve crush induces proliferation of microglia and phagocytic clearance of neuronal debris**. **(A)** Scheme of CTB-labeling and optic nerve crush paradigm. **(B--E)** Representative images (B) and quantification (C) of the degenerating dLGN presynaptic field, Iba1+ (D), and Iba1/Ki67+ cells (E; *n* = 4--7 mice per group; one-way ANOVA, Dunnett's post hoc, representative of two independently performed experiments). **(F and G)** Representative images (F) and quantification (G) of VGlut2/PSD95+ retinogeniculate synapse loss 3 d after optic nerve crush (*n* = 3 mice per group; Student's *t* test, representative of two independently performed experiments). **(H--K)** Scheme (H), representative images (I), and quantification of the number (J) and proliferation (K) of Iba1+ and Iba1/ZsGreen+ cells in *Cx3cr1*^ERT2Cre/+^:Ai6 mice prior and 3 d after optic nerve crush (*n* = 4 mice per group; two-way ANOVA with Holm-Sidak post hoc test \[J\], Student's *t* test \[K\], representative of three independently performed experiments). **(L and M)** Z projections, orthogonal slices, Imaris three-dimensional reconstructions (L) and quantification (M) of microglial phagocytosis of crushed retinogeniculate inputs (*n* = 4--6 mice per group; one-way ANOVA, Dunnett's post hoc test, representative of two independently performed experiments). **(N--P)** Representative images (N) and quantification of Iba1+ cells (O) and CTB+ fields (P) in uninjured and 3 d postinjury PLX5622 and control chow-fed mice (*n* = 7--8 mice per group; Student's *t* test, representative of three independently performed experiments). Error bars represent mean ± SEM. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; n.s., not significant. Bars: 100 µm (B, I, and N); 25 µm (F); 10 µm (L).](JEM_20172244_Fig1){#fig1}

To demonstrate that the gradual disappearance of CTB labeling actually corresponded to the loss of presynaptic terminals, we quantified retinogeniculate synapses in areas of CTB loss within the dLGN contralateral to the crushed eye on day 3 after optic nerve crush injury. Using a method previously used to count synapses of the mouse visual system ([@bib35]), we observed a significant decrease in retinogeniculate (VGlut2/PSD95 double-positive) synapses ([Fig. 1](https://www.ncbi.nlm.nih.gov/unigene/46282,1353877,5896161), F and G), suggesting that the disappearance of CTB observed after the injury was indeed related to the loss of retinogeniculate terminals.

The optic nerve crush injury model is unique in that it allows for the study of cellular responses to neurodegeneration that occur far from the actual site of injury. This is particularly important when attempting to isolate the role of microglia, as the injury site is heavily populated by peripheral cells ([@bib71]) that may compete and even interfere with microglial function and complicate microglial identification. We first needed to confirm that, in the context of neurodegeneration, the microglia in our system could indeed be studied in isolation from contamination by peripheral macrophages. We did this by fate labeling microglia, using *Cx3cr1*^ERT2Cre/+^:Ai6 mice. Using a previously published protocol ([@bib26]), mice were fed tamoxifen-containing chow for 1 wk and then waited 1 mo for peripheral myeloid cell turnover before we analyzed the brain and peripheral organs for macrophage expression of ZsGreen (Fig. S1 A). We observed that nearly 100% of microglia retained ZsGreen labeling in the uninjured cerebral cortex and cerebellum (Fig. S1, B--D). This contrasted with peripheral macrophage populations, which exhibited decreasing percentage of ZsGreen+ myeloid populations in the spleen, liver, and blood, respectively (Fig. S1, B--D). We then performed unilateral optic nerve crush and sacrificed the injured mice 3 d later ([Fig. 1 H](#fig1){ref-type="fig"}). Both before and after crush injury, the vast majority of myeloid cells (Iba1+) in the dLGN were ZsGreen+ ([Fig. 1, I and J](#fig1){ref-type="fig"}). Unlike in the dLGN, the injury site in the optic nerve had numerous Iba1^+^/ZsGreen^--^ cells, indicative of peripheral myeloid engraftment there (Fig. S1 E), as has been previously reported ([@bib71]). Furthermore, there was no difference in the percentages of Iba1+ or Iba1+/ZsGreen+ cells expressing Ki67 in dLGN after injury ([Fig. 1, I and K](#fig1){ref-type="fig"}), implying that the Iba1+ cells were derived from endogenous microglial populations. Despite retention of ZsGreen labeling after nerve crush injury, a marked reduction in the microglia-specific marker TMEM119 ([@bib7]) was seen on microglia 3 d postinjury (Fig. S2, A and B). This shows that activation leads to loss of TMEM119 expression by endogenous microglia as has been previously shown in a mouse model of Alzheimer's disease ([@bib36]). Therefore, caution should be used when interpreting TMEM119 labeling of microglia, as loss of this marker may be indicative of microglial activation in general.

The unique model we describe here incorporates crush injury of the optic nerve and the consequent neurodegeneration in the dLGN, distal to the injury site itself. Thus, this allows a "closed system" to study phagocytic uptake of neuronal material with no prior priming of microglia or peripheral myeloid "contamination."

Because microglia have been shown to be prolific phagocytes of synaptic material ([@bib53]), we examined whether the observed phagocytosis and clearance of presynaptic terminals were attributable to dLGN microglia. Using a previously described method ([@bib54]), we observed that neuronal debris (presented as the percentage of microglial volume) was indeed present within the microglial soma ([Fig. 1, L and M](#fig1){ref-type="fig"}). In *Cx3cr1*^GFP/+^ mice, costaining for engulfed neuronal debris alongside the phagolysosomal marker CD68 revealed a high degree of internalized CTB colocalized with the microglial phagolysosome (Fig. S2 C), indicative of microglial phagocytosis.

Although microglia are known to play a role in the pruning of synapses during the developmental period of eye-specific segregation at postnatal day 5, it was suggested that, given the amount of consumed neuronal material, the dominant phagocytes at that stage were astrocytes ([@bib13]). To assess the possibility that astrocytes could be phagocytic of neuronal debris after optic nerve crush injury, we quantified the number of cells positive for the astrocyte marker, glial fibrillary acidic protein (GFAP), after injury (Fig. S2, D and E). Neither a change in GFAP+ cell number nor CTB+ debris within GFAP+ cells was observed (Fig. S2, F and G).

As a result of the limitations of GFAP as a gray matter astrocyte marker ([@bib47]), we further assessed the phagocytic capabilities of LGN astrocytes and microglia during acute Wallerian degeneration using flow cytometry. Bilateral CTB-A647 injection and crush injury were performed, followed by LGN microdissection 3 d later (Fig. S2, H and I). Although a significant increase in the amount of CTB was only seen in the microglial population, we did see a small, yet not significant, increase in CTB+ astrocyte populations with CTB injected eyes in both uninjured and postcrush conditions (Fig. S2, J and K). To distinguish whether this positivity was a result of internalization of CTB or extracellular attachment, we used a CTB conjugated to the pH-sensitive dye CypHer 5E. This compound is maximally fluorescent at low pH with minimal fluorescence at neutral pH ([@bib17]). Thus, only cells with engulfed CTB should exhibit CypHer positivity. After bilateral eye injection with CTB-CypHer followed by optic crush, only CypHer+ microglia, and not astrocytes, were observed (Fig. S2, L and M).

To assess the necessity of microglia in the clearance of neuronal debris after injury in adult mice, we eliminated microglia in our system by using the CSF 1 receptor (CSF1R) inhibitor PLX5622, a compound previously shown to efficiently deplete microglia in the CNS ([@bib22]). After 3 wk of treatment with PLX5622 chow, mice received bilateral injections of CTB intravitreally and were subjected 24 h later to unilateral optic nerve crush injury. As previously shown ([@bib32]), PLX5622 treatment also had no effect on RGC survival 3 (Fig. S2, N and O) and 7 d after optic nerve crush injury (Fig. S2, P and Q). As expected, PLX5622 also resulted in a marked reduction in microglial counts ([Fig. 1, N and O](#fig1){ref-type="fig"}). Subsequently, CTB+ dLGN fields contralateral to crushed optic nerves were significantly larger 3 d after optic nerve crush injury in PLX5622-fed mice than in mice fed control chow, suggesting that after optic nerve crush injury, microglia are necessary for the optimal clearance of neuronal debris ([Fig. 1, N and P](#fig1){ref-type="fig"}). In fact, microglial depletion and debris presence persisted in PLX5622-fed mice up to 7 d after optic nerve crush injury (Fig. S2, R--T). No changes were seen in CTB-labeled presynaptic inputs into the dLGN contralateral to uninjured optic nerves ([Fig. 1, N and P](#fig1){ref-type="fig"}; and Fig. S2, R and T). These results suggest that microglia are the key phagocytes of dLGN presynaptic debris during Wallerian degeneration in our system. This is in contrast to the situation during developmental pruning, where astrocytes are the dominant phagocyte ([@bib13]). A recent study has also shown that microglia are capable of modulating astrocyte function through soluble factors, allowing for their reactivity and enhanced function ([@bib43]). Although microglial depletion may alter astrocyte function and thus removal of neuronal debris, it appears that microglia are the key cell responsible for debris engulfment after Wallerian degeneration of the optic nerve.

Neuronal activity is not the trigger for microglia activation after optic nerve crush injury {#s04}
--------------------------------------------------------------------------------------------

The rapid response of dLGN microglia observed after optic nerve crush prompted us to investigate whether neuronal activity from the retina, shown to be crucial for engulfment of neuronal material in development ([@bib53]), might regulate microglial activation in response to this injury, especially because all neuronal activity from the retina is known to be rapidly disrupted after optic nerve crush in the mouse. To address this question, we used *Wld^S^* mice ([@bib14]), which demonstrate delayed axonal and synaptic degeneration after acute injury to the peripheral and central nervous systems ([@bib25]; [@bib69]; [@bib74]). Thus, by studying the microglia in the acutely injured *Wld^S^* dLGN, we were able to examine a system in which neuronal activity had ceased (as in the injured WT), but presynaptic degeneration was markedly delayed ([Fig. 2, A and B](#fig2){ref-type="fig"}). Before examining the dLGN we counted the RGCs in *Wld^S^* mice 3 d after optic nerve crush and observed no changes in their numbers (Fig. S3, A and B). We then examined the dLGN and found significantly less microglia in the dLGN contralateral to the crushed eye of *Wld^S^* mice than in their WT counterparts, indicating that little or no dLGN microglial proliferation had occurred in the *Wld^S^* mice by day 3 after the optic nerve crush ([Fig. 2, C and D](#fig2){ref-type="fig"}). The CTB+ field of the dLGN contralateral to the crushed optic nerve was also significantly larger in the *Wld^S^* mice, indicating a reduced microglial clearance of the CTB+ presynaptic field in *Wld^S^* mice ([Fig. 2, C and E](#fig2){ref-type="fig"}). CTB+ field size in the dLGN of *Wld^S^* mice contralateral to the uninjured optic nerve were unchanged ([Fig. 2, C and E](#fig2){ref-type="fig"}), indicating that, as shown previously ([@bib34]), there were no developmental changes in retinogeniculate projections in *Wld^S^* mice. Coinciding with the reduction in microglia number was a decrease in Ki67+ microglia, implying that microglial proliferation is greatly diminished when neurodegeneration is delayed ([Fig. 2, F and G](#fig2){ref-type="fig"}). Our analysis of microglial activation and phagocytosis of crushed neuronal inputs in the *Wld^S^* mice also revealed a less activated morphology and significantly less engulfed neuronal debris than in WT microglia at 3 d after injury ([Fig. 2, H and I](#fig2){ref-type="fig"}).

![**Microglial activation and phagocytosis after optic nerve crush injury is triggered by synaptic degeneration and not cessation of neuronal activity. (A and B)** Scheme of conceptual (A) and experimental (B) setup of optic nerve injury in WT and *Wld^S^* mice. **(C--E)** Representative images (C) and quantification of Iba1+ cells (D) and dLGN CTB fields (E) 3 d after optic nerve crush in WT and *Wld^S^* mice (*n* = 5--8 mice per group; Student's *t* test, representative of three independent experiments). **(F and G)** Representative images (F) and quantification (G) of Ki67+ dLGN microglia 3 d after optic nerve crush in WT and *Wld^S^* mice (*n* = 5--8 mice per group; Student's *t* test, representative of three independent experiments). **(H and I)** Z projections, orthogonal slices, Imaris three-dimensional reconstructions (H), and quantification (I) of microglial phagocytosis of crushed retinogeniculate inputs in WT and *Wld^S^* mice 3 d after optic nerve crush (*n* = 5--8 mice per group; Student's *t* test, representative of three independent experiments). **(J)** Scheme of TTX application and crush injury. **(K and L)** Z projections, orthogonal slices, Imaris three-dimensional reconstructions (K), and quantification (L) of microglial phagocytosis after TTX application and crush injury (*n* = 7--13 mice per group, pooled from two independent experiments; two-way ANOVA for effect of optic nerve crush, Holm-Sidak post hoc test). Error bars represent mean ± SEM. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001. n.s., not significant. Bars: 100 µm (C and F); 20 µm (H and K).](JEM_20172244_Fig2){#fig2}

To further determine whether presynaptic terminals lacking neuronal activity from the retina could be engulfed by injury-activated microglia, we took advantage of the dLGN architecture (consisting of a small ipsilateral patch within the large contralateral projection area). Using pharmacological attenuation of neuronal activity in the ipsilateral eye concurrently with optic nerve crush in the contralateral eye, we tested whether injury-activated microglia would engulf weakened inputs (from the ipsilateral patch, [Fig. 2 J](#fig2){ref-type="fig"}). To this end, we labeled retinogeniculate inputs with CTB conjugated to Alexa Fluor dyes, and 24 h later applied tetrodotoxin (TTX) or its carrier (citrate buffer) to one eye, effectively blocking action potential--mediated activity from the eye, while crush injuring the contralateral optic nerve. To confirm that TTX had an effect on dampening neuronal activity from the eye, we examined the pupillary constriction response ([@bib63]; [@bib58]) in our mice 24 and 48 h after the above procedures. Significant effects of both the optic nerve crush and the TTX application on pupillary constriction reflexes were observed both at 24 and at 48 h after the injury, with no detectable effect on naive eyes or on citrate buffer--treated controls (Fig. S3, C--F). The mice were killed 3 d after crush, during peak phagocytosis of crushed neuronal inputs. Examination at that time (3 d after crush injury) showed that there were no effects of TTX on RGC survival (Fig. S3, G and H). dLGN microglia counts were also unchanged contralateral to eyes treated with TTX, with only dLGN microglia contralateral to the crushed eye showing an increase in number (Fig. S3, I and J). We also found that the CTB+ presynaptic field sizes contralateral to TTX-treated eyes were unchanged compared with either naive or citrate buffer--treated eyes, with only dLGN CTB fields contralateral to crushed eyes decreasing in size (Fig. S3, I and K). Next, we examined whether injury-activated microglia would phagocytose TTX-treated uninjured presynaptic terminals. We found that microglia engulfed neuronal material from the crushed eye but did not engulf TTX-treated inputs ([Fig. 2, K and L](#fig2){ref-type="fig"}), which were deficient in action potential--mediated activity from the eye.

Although TTX application did serve to block activity emanating from the eye, spontaneous release of neurotransmitter from presynaptic terminals would not be affected by TTX treatment ([@bib11]). Still, this lack of microglia dependence on retinal activity distinguishes the dLGN microglial phagocytosis seen in development ([@bib53]) from that observed during CNS Wallerian degeneration. Reasons for this may include, for example, differences between the effect of neuronal activity on the membrane properties of presynaptic terminals of retinogeniculate inputs during adulthood and during a critical period in development. Another possibility is that there are physiological differences in postnatal day 5 dLGN microglia versus those seen in adult microglia during Wallerian degeneration. Finally, an actively degenerating presynaptic terminal seen after nerve crush might be more salient to activated microglia than a presynaptic terminal treated with TTX, allowing microglia to interact more robustly with degenerating terminals than with those having less neuronal activity. These results demonstrate that in the adult mouse, microglia become activated in response to synaptic degeneration, whereas cessation of neuronal activity has no effect on microglial phagocytic activity.

Transcriptional profiling of dLGN microglia after optic nerve crush {#s05}
-------------------------------------------------------------------

Because microglia are the main phagocytes in response to neurodegeneration in the dLGN, these findings provide an amenable system for studying molecular mechanisms governing microglial engulfment of endogenous material. Thus, to identify the genetic programs necessary for removal of neuronal debris by dLGN microglia, we isolated CD11b+ cells (using AutoMACS) from an uninjured state and at 1 and 3 d after bilateral optic nerve crush ([Fig. 3 A](#fig3){ref-type="fig"}). RNA sequencing (RNA-seq) was performed on our samples after flow cytometry confirmed that each sample was at least 90% CD11b+CD45+ (Fig. S3, L--N). Principal component analysis of all statistically significant transcripts revealed three discretely clustered populations, indicating a unique transcriptional signature for postinjury microglia at both time points tested ([Fig. 3 B](#fig3){ref-type="fig"}). Notably, day 1 and 3 microglial subsets did not cluster together more closely than in the uninjured condition, indicating a dynamic transcriptional profile of microglia in the acute phase of Wallerian degeneration. To assess the differences between genes expressed on days 1 and 3 after crush injury, we compared the uniquely enriched genes of each condition to uninjured controls ([Fig. 3 C](#fig3){ref-type="fig"}). We found 132 common genes enriched in microglia on both days 1 and 3 after crush injury (adjusted p-value \< 0.05), with the 3-d postinjury microglia expressing the higher amount of uniquely enriched genes after the injury (1,216 unique genes on day 3 compared with 697 unique genes on day 1 after crush). To illustrate the functional differences between dLGN microglia at 1 and 3 d after crush injury, we identified gene sets enriched on days 1 and 3 by performing a gene set enrichment analysis. This revealed that several gene sets were down-regulated in microglia on day 1 after crush injury, including those associated with the extracellular matrix and biological adhesion ([Fig. 3 D](#fig3){ref-type="fig"}). Up-regulated gene sets on day 1 after injury included those associated with sensing molecular "danger," such as complement ([Fig. 3 E](#fig3){ref-type="fig"}) and NOD-like receptor and Toll-like receptor signaling pathways ([Fig. 3 F](#fig3){ref-type="fig"}), indicating that microglia at 1 d after crush injury indeed sense and respond to the ongoing accumulation of neuronal debris. Gene sets down-regulated on day 3 after the injury included regulation of hydrolase, GTPase, and catalytic activity, as well as regulation of immune system processes. Up-regulated gene sets included genes necessary for ribosome and proteasome production, cell cycle processes, oxidative phosphorylation, phagocytosis ([Fig. 3 G](#fig3){ref-type="fig"}), and Alzheimer's disease ([Fig. 3 H](#fig3){ref-type="fig"}). This diverse array of gene sets would be expected for microglial cells that are surrounded by neuronal debris, actively engaged in phagocytosis, and undergoing cell division. Interestingly, the transcriptional signature 3 d after injury is distinct from that of 1 d after injury, with just 132 genes enriched on both postinjury days compared with noninjured condition. That such a unique transcriptional signature of microglia could be displayed only 2 d apart is unique, as most transcriptional studies to date have examined microglial activation on a longer time scale ([@bib12]; [@bib31]; [@bib10]; [@bib36]). This speed of change is likely indicative of the responsive and plastic nature of microglia. Further studies examining microglial transcriptomes on a more acute basis after insult or during chronic disease may yield even more insights into microglial biology in health and disease. Recently, microglial activation genes associated with neurodegeneration have been characterized ([@bib36]; [@bib38]). After crush, several of these genes were also up-regulated in LGN microglia 3 d after injury (Fig. S3 O), indicating that there may be a core program of microglial activation central to both acute and chronic neurodegenerative processes. Despite this finding, key genes shown previously to be necessary for the chronic neurodegenerative signature (*Trem2* and *Apoe*) were not up-regulated, indicating that there may still be differences in the activation profiles of microglia in acute and chronic neurodegenerative settings.

![**dLGN microglia after optic nerve crush exhibit a dynamic transcriptional profile using C1q and CD11b for optimal clearance of neuronal debris. (A)** Scheme of dLGN microglia isolation. **(B)** PCA analysis of microglia after injury. **(C)** UpSet plot detailing enriched genes after crush. **(D)** Gene sets enriched in dLGN microglia after crush. **(E--H)** Heat maps of complement (E), TLR signaling (F), phagocytosis (G), and Alzheimer's disease (H) gene sets up-regulated in dLGN microglia after crush. **(I)** Normalized read counts of selected complement genes in microglia after crush (*n* = 2 samples for uninjured microglia and *n* = 3 samples for one and 3 d after crush, Fisher's test, performed once). **(J--L)** Representative images (J) and quantification of microglia (K) and dLGN CTB fields (L) 3 d after optic nerve crush in *C1qa^+/+^* and *C1qa^−/−^* mice (*n* = 8--9 mice per group; Student's *t* test, representative of two independent experiments). **(M--O)** Representative images (M) and quantification of microglia (N) and dLGN CTB fields (O) 3 d after optic nerve crush in WT and *Itgam^−/−^* mice (*n* = 5 mice per group; Student's *t* test, representative of two independent experiments). Error bars represent mean ± SEM. \*, P \< 0.05; \*\*\*, P \< 0.001; n.s., not significant. Bars, 100 µm.](JEM_20172244_Fig3){#fig3}

Because the complement gene set was up-regulated on day 1 after crush injury, we examined specific complement genes associated with the microglial engulfment of neuronal material during development ([Fig. 3 I](#fig3){ref-type="fig"}). The results showed that *Itgam* (CD11b or C3R) was highly up-regulated in microglia on day 1 after optic nerve crush. We also observed a slight (not statistically significant) increase in transcription of *C1qb* and *C1qc*. To determine whether the complement system plays a role in the microglial clearance of neuronal debris after optic nerve crush, we repeated optic nerve crush injury experiments using *C1qa*^−/−^ and *Itgam*^−/−^ mice. On day 3 after optic nerve crush, we observed no change in the number of microglia in *C1qa*^−/−^ mice ([Fig. 3, J and K](#fig3){ref-type="fig"}), whereas significantly more residual neuronal debris was seen compared with WT mice ([Fig. 3, J and L](#fig3){ref-type="fig"}). Similarly, *Itgam*^−/−^ mice showed no change in the number of microglia after injury ([Fig. 3, M and N](#fig3){ref-type="fig"}), and exhibited more neuronal debris in the dLGN contralateral to the crushed eye as compared with their WT counterparts ([Fig. 3, M and O](#fig3){ref-type="fig"}). Importantly, RGC survival was not affected by deficiency of C1q (Fig. S3, P and Q) or CD11b (Fig. S3, R and S). Altogether, these experiments indicated an active role for complement in the microglial clearance of neuronal debris pursuant to Wallerian degeneration, implicating complement as a key driver of neuronal material clearance by microglia in Wallerian degeneration, shown previously in development ([@bib61]), Alzheimer's disease ([@bib33]), schizophrenia ([@bib57]), and viral infection ([@bib70]).

In this study, we provide a novel platform for the study of physiological microglial phagocytosis pursuant to Wallerian degeneration. We further show that microglia are the key players in the clearance of neuronal debris, that their depletion results in failed debris clearance, and that neuronal activity is irrelevant for the activation and initiation of phagocytosis by microglia.

Notable in our transcriptional findings were microglial profiles characterized by up-regulation of TLR, NLR, and Alzheimer's disease gene sets. An up-regulation of such programs could very well be a result of the release or exposure of damage-associated molecular patterns (DAMPs) by degenerating nerve terminals. Future studies attempting to identify microglial-activating DAMPs in the context of acute injury may yield important insights into microglial responses to neurodegeneration in a larger context. The importance of neurodegeneration and exposure of DAMPs was seen with crush in *Wld^S^* mice, where the lack of neurodegeneration was accompanied by no induction of microglial proliferation. A possible mediator could be phosphatidyl serine exposure on presynaptic terminals, which could be diminished in the *Wld^S^* LGN after crush. Phosphatidyl serine exposure has been shown previously to be essential to induce microglial proliferation in response to neurodegeneration in the context of CNS viral injection ([@bib66]).

Future research may yield further insights into the sensors that allow for microglial activation in response to neurodegeneration, as well as into the array of receptors needed to facilitate debris removal. Knowledge of these tools might aid in the tuning of microglial function by limiting the spread of secondary neurodegeneration or by boosting the microglial clearance of potentially toxic debris. Consequences of failed debris clearance in the periphery have been well characterized, and lead to inflammation and subsequent autoimmune disease ([@bib21]). We suggest that the same may hold true in the CNS, where absence or dysfunction of microglial phagocytosis may ultimately lead to neuronal dysfunction and disruption of CNS homeostasis.

Materials and methods {#s06}
=====================

Mice {#s07}
----

C57/Bl6 and *Cx3cr1*-eGFP mice were obtained from Jackson Laboratory, stocks 000664 and 005582, respectively. B6.Cg-*Gt(ROSA)26Sor^tm6(CAG-ZsGreen1)Hze^*/J (Ai6) mice were generously provided by the Harris Lab (University of Virginia) and originally obtained from Jackson Laboratories (Stock 007906). *Wld^S^* mice were provided by the Deppmann Lab (University of Virginia, Charlottesville, VA) and originally obtained from Jackson Laboratories (008820) and bred with congenic FVB/N mice to obtain heterozygous *Wld^S^* mice and WT controls. *Itgam^−/−^* mice and their congenic C57/Bl6J controls were purchased from Jackson Laboratories (stock 003991 and 000664, respectively). Heterozygous *C1qa^+/−^* mice were obtained from Jackson Laboratories (stock 022307) and bred to obtain *C1qa^−/−^* and *C1qa^+/+^* control mice. All strains were kept in identical housing conditions. All animals were housed in temperature and humidity-controlled rooms, maintained on a 12-h light/dark cycle (lights on 7 a.m.); mice were used from 2 to 4 mo old with mice age-matched in each experiment described. For survival surgeries, mice were anesthetized with either 200 µl of Ketamine/Xylazine (1 ml Ketamine HCl \[1 mg/ml\], 1 ml of 2% Xylazine, and 8 ml saline), or inhaled isoflurane. All procedures complied with regulations of the Institutional Animal Care and Use Committee at the University of Virginia.

Fate mapping of microglia {#s08}
-------------------------

B6.Cg-*Gt(ROSA)26Sor^tm6(CAG-ZsGreen1)Hze^*/J mice (Ai6) were crossed to the *Cx3cr1*^ERT2cre/ERT2cre^ mice to obtain *Cx3cr1*^ERT2/+^:Ai6 heterozygotes. Mice were placed on a tamoxifen-supplemented (250 mg/kg) diet for 1 wk (TD.130856 Envigo). After return to normal chow, a period of 1 mo was allowed to ensure turnover of the peripheral immune system, allowing only microglia to retain the ZsGreen label ([@bib26]). Mice were then subjected to analysis or optic nerve crush injury and sacrificed 3 d after injury.

PLX5622 administration {#s09}
----------------------

PLX5622 was provided by Plexxikon Inc. and formulated in AIN-76A standard chow by Research Diets Inc. at 1,200 mg/kg. Mice were kept on PLX5622 or AIN-76A control diets for 3 wk before experimentation and maintained on their respective diets until sacrifice.

CTB-CypHer preparation {#s10}
----------------------

Cholera toxin β subunit (C9903; Sigma-Aldrich) was resuspended at 10 mg/ml in PBS and labeled with CypHer5 (10 µM; GE Healthcare) for 1 h at 20°C. Free dye was removed by gel filtration using Zeba desalting column (89890; Thermo Scientific) according to manufacturer's instructions. Reagent preparations were performed by the Gaultier Lab (University of Virginia).

CTB injection and optic nerve injury {#s11}
------------------------------------

After anesthesia, mice received intravitreal injections of CTB conjugated to Alexa Fluor 555 dye into the left eye and CTB conjugated to Alexa Fluor 647 (Invitrogen) dye into the right eye (1 µl per eye at a concentration of 1 µg/µl in sterile saline). Optic nerve crush was performed 24 h after CTB injection. In brief, mice were anesthetized and the tissue around the nerve was carefully dissected and the optic nerve exposed. N5 self-closing forceps were closed around the optic nerve 5 mm behind the globe and held for 3 s. The mice were then allowed to recover at 37°C on a warming pad before returning to their cages and sacrificed at time points indicated in the text. (Mice that did not receive sufficient dLGN dye fills were omitted from analysis.)

TTX administration and measurement of pupil response {#s12}
----------------------------------------------------

Once anesthetized, 1 µl TTX (5 µM) or its carrier solution (20 mM citrate buffer) was injected intravitreally with a Hamilton syringe contralateral to the eye used for optic nerve crush. Pupil response was measured as described previously ([@bib58]). In brief, at time points 24 and 48 h after optic nerve crush injury and TTX administration, mice were acclimated to a dark room for 30 min before testing. While under a red light (Black Diamond Cosmos), the pupil size was obtained using a Leica IC80HD camera fixed to a Leica M220 dissecting microscope. The mouse was then subjected to a 15-s exposure of bright white light and the pupil size was imaged instantly after return to red light conditions. The percentage pupil constriction was calculated as the difference in pupil size between red and bright white light conditions.

Tissue preparation and immunofluorescence {#s13}
-----------------------------------------

The brain and eyes were harvested from animals after perfusion with heparinized (5 U/ml) PBS and 4% paraformaldehyde (PFA). After 24 h postfixation in 4% PFA, the eye was dissected by cutting through the sclera just posterior to the ciliary body. The lens was removed, and four cuts were made toward the optic disc to allow the retina to lay flat. The retina was then separated from the sclera and pigmented epithelium and placed in to 96-well plates for staining. Brain tissue was postfixed for 48 h in 4% PFA, followed by cryoprotection in 30% sucrose for 48 h. Brains were then frozen in optimal cutting temperature compound (Tissue-Tek) on the freezing element of a Leica CM3050 S cryostat. 40-µm sections were sliced into 24-well plates containing PBS with 0.05% sodium azide. Slices were permeabilized with 0.5% Triton X-100 for 15 min then washed two times for 5 min in PBS and blocked for 1 h at room temperature in blocking buffer (5% serum of the secondary\'s species) followed by overnight incubation in 0.5% BSA with primary antibody at 4° C. The following antibodies were used for immunofluorescence staining: rabbit anti-Iba1 (1:300; CP-290; Biocare Medical), goat anti-BRN3a (1:300; sc-31984; Santa Cruz), rabbit anti-Ki67 (1:300; ab15580; Abcam), Goat anti-Iba1(1:300; Abcam; ab5076), rat anti-CD68 (FA-11; Biolegend), rabbit anti-TMEM119 (ab209064; Abcam**)** guinea pig anti-Vglut2 (AB2251; EMD Millipore) rabbit anti--PSD-95 (51-6900; Invitrogen). Slices were washed three times for 5 min, incubated for 2 h at room temperature with the appropriate secondary antibodies (all from Life Technologies; 1:1,000), washed again three times for 5 min and mounted with Aquamount (Thermo Scientific) and DAPI.

RGC image acquisition and quantification {#s14}
----------------------------------------

For assessing RGC survival, images of Brn3a+ RGCs from four quadrants of the retina were taken at equal distances from the optic disc using an Olympus IX-71 microscope with 40× objective. The pictures were counted in a blinded fashion to determine the number of RGCs per field. RGC counts were established from each image using a modified method described previously ([@bib18]). In brief, each image was inverted with the contrast enhanced (1%) and background subtracted (rolling ball 55). Each image was then set to a threshold to encompass all Brn3a+ cells. Once binary, the Watershed feature was applied and the Analyze Particle function used to count all RGCs. All images were acquired and quantified by a user blinded to the experiment.

dLGN image quantification and analysis {#s15}
--------------------------------------

For each animal, three to four sections of medial dLGN were chosen for imaging and quantification of RGC inputs to the dLGN, Iba1+ cell counts and microglial engulfment analysis. Images were acquired on a Leica SP8 microscope at 20× magnification with 1-µm z steps for CTB field size measurements and Iba1+ cell counts and at 60× magnification using 0.2-µm z steps for engulfment analyses. For each animal, four to seven dLGN fields were imaged. Obtained images were processed and quantified using ImageJ (National Institutes of Health) for CTB field size and Iba1+ cell number and Imaris software (Bitplane) for engulfment analyses. For CTB field size and Iba1+ cell number, ImageJ was used to obtain regions of interest (ROIs) of contralateral dLGN fields for crushed and uninjured inputs. Each ROI was then thresholded to include all CTB+ inputs, and the area was measured. Iba1+ counts were made using the Cell Counter plugin (ImageJ). In vivo microglia phagocytosis assays and analyses were performed as previously described in detail ([@bib53], [@bib54]). Imaris software (Bitplane) was used to create three-dimensional volume surface renderings for microglia and engulf debris. To visualize and measure debris volume, any fluorescence that was not within the microglia volume was subtracted from the image using the mask function of Imaris. The remaining engulfed fluorescence was surface rendered and total volume of engulfed debris was calculated. To determine percentage engulfment the following calculation was used: volume of internalized debris /volume of microglial cell × 100. Image acquisition, quantification, and analyses were performed blind.

Retinogeniculate synapse quantification {#s16}
---------------------------------------

Quantification of retinogeniculate synapses was performed as described previously ([@bib35]). In brief, dLGN brain sections from uninjured and 3-d postcrush mice were stained with pre (VGlut2) and postsynaptic (PSD95) markers. 5-µm-thick confocal z stacks (optical section depth, 0.33 µm; 15 sections per z stack) within the outer shell were imaged at 60× magnification on a Leica SP8 confocal laser-scanning microscope. Maximum projections of three consecutive sections (corresponding to 1 µm total depth) were generated from the original z stack. The Puncta Analyzer plugin that was developed by Barry Wark for ImageJ (available at <https://github.com/physion/puncta-analyzer>) was used to count the number of colocalized puncta.

Flow cytometry of LGN astrocytes and microglia to assess engulfment of neuronal material {#s17}
----------------------------------------------------------------------------------------

After anesthesia, mice received intravitreal injections of CTB conjugated to Alexa Fluor 647 dye or CypHer in to both eyes (1 µl per eye at a concentration of 1 µg/µl in sterile saline). Optic nerve crush was performed 24 h after CTB injection. 3 d after bilateral optic nerve crush, mice were perfused with PBS containing heparin (5 U/ml) until livers and tongues were exsanguinated to minimize peripheral immune cell contamination. The entire brain was then removed, and meninges and choroid plexus were carefully separated and discarded from the rest of the brain tissue. The brain was then placed in a coronal brain matrix (SA-2165; Roboz), and a razor blade was used to isolate a brain slice containing the dLGN. The dLGN was dissected from surrounding brain regions and placed in 1.5 ml Accutase (A1110501; Stempro) in a 1.5-ml Eppendorf tube. Samples were then incubated at 37°C for 15 min, followed by gentle trituration five times up and down with a 1,000-µl Eppendorf pipette. Samples were again incubated at 37°C for 10 min, followed by a second gentle trituration five times up and down with a 1,000-µl Eppendorf pipette. At this point, cells were well dissociated. The 1.5-ml suspension was then filtered gently through a 70-µm cell strainer and placed in 15-ml tubes containing 14 ml DMEM/F12/ with 10% FBS. Cells were then pelleted at 300 relative centrifugal force (RCF) for 10 min. Cells were then stained for 15 min at 4°C using antibodies against CD11b (PercpCy5.5), CD45 (FITC; both from R&D Systems), GLAST (PE, Miltenyi) as well as the viability dye ZombieNIR (Biolegend) and Hoechst dye (Molecular Probes) to label all nucleated cells. Cells were then washed and spun at 300 RCF for 10 min at 4°C and resuspended in FACS buffer (2 mM EDTA and 0.5% BSA in PBS) and ran on a Gallios flow cytometer (Becton Dickinson). Positive fraction cells gated on Hoechst positivity, singlet events, and live cells before their respective gates. CTB positivity was set on naive populations.

dLGN dissection, MACS isolation of microglia, and RNA extraction {#s18}
----------------------------------------------------------------

3 d after bilateral optic nerve crush, mice were perfused with PBS containing heparin (5 U/ml) until livers and tongues were exsanguinated to minimize peripheral immune cell contamination. The entire brain was then removed and meninges and choroid plexus carefully separated and discarded from the rest of the brain tissue. The brain was then placed in a coronal brain matrix (Roboz SA-2165) and a razor blade used to isolate a brain slice containing the dLGN. The dLGN was dissected from surrounding brain regions and placed in 1 ml HBSS (containing Mg and Ca), 4 U/ml papain, and 50 U/ml DNASE-I (Sigma-Aldrich) in a 1.5-ml Eppendorf tube. Bilateral dLGNs were pooled from four mice to serve as one biological sample (three samples per condition). Samples were then incubated at 37°C for 15 m, followed by gentle trituration five times up and down with a 1,000-µl Eppendorf pipette. Samples were again incubated at 37°C for 15 min, followed by a second gentle trituration five times up and down with a 1,000-µl Eppendorf pipette. At this point, cells were well dissociated. The 1-ml suspension was then filtered gently through a 70-µm cell strainer and placed in 15-ml tubes containing 14 ml DMEM/F12 with 10% FBS. Cells were then pelleted at 300 RCF for 10 min. The top of the gradient was then removed. Cells were then labeled with microglia CD11b+ magnetic selection beads (Miltenyi). Cells were positively selected by AutoMACS twice using the Possel setting. All 15-ml tubes before use were coated with sterile BSA in diethyl pyrocarbonate--treated PBS to ensure optimal recovery of microglia. Flow cytometry was used to ensure purity of the positive and negative fraction of AutoMACS sorted cells. 5% of each fraction was isolated and stained for 15 min at 4°C using antibodies against CD11b (PE-Cy7) CD45 (BB515; both from R&D Systems), as well as the viability dye ZombieNIR (Biolegend) and Hoechst dye (Molecular Probes) to label all nucleated cells. Cells were then washed and spun at 300 RCF for 10 min at 4°C and resuspended in 1% PFA in PBS, and samples were run on a Gallios flow cytometer (Becton Dickinson). Positive fraction cells gated on Hoechst positivity, singlet events, and live cells were \>90% pure CD45/CD11b+ microglia with the negative fraction \<1%. RNA was collected using the RNAqueous micro kit (Ambion) according to the manufacturer's protocol and stored at −80°C until use.

RNA-seq {#s19}
-------

RNA integrity was verified using the Qubit RNA assay kit (Life Technologies) and the Agilent RNA Pico kit (Agilent). Amplification and cDNA construction was performed using Nugen Ovation RNA-seq V2 kit with manufacturer\'s recommended protocol. Sample clean-up after amplification was performed using Qiagen PCR purification kit (Qiagen). Paired-end (50-bp reads) RNA-seq was performed using an Illumina HiSeq (Illumina) yielding 50--70 million reads per sample. All procedures were performed by HudsonAlpha.

RNA-seq analysis {#s20}
----------------

The raw sequencing reads (FASTQ files) went through two stages of preprocessing to remove low-quality reads and bases. First, they were chastity filtered, which removes any clusters that have a higher than expected intensity of the called base compared with other bases. Then they were trimmed with Trimmomatic ([@bib9]) to remove low-quality bases (minimum read length after trimming = 36). After preprocessing, the quality of the reads was evaluated using FastQC ([@bib3]), and after passing quality control, were aligned to the UCSC mm9 genome ([@bib30]) using the splice-aware read aligner STAR ([@bib20]). The quality of the alignments was next assessed by SAMStat ([@bib40]), and any low-quality alignments were removed with samtools ([@bib42]; mapping quality \<10). Next, the number of reads aligning to each gene was quantified with HTSeq ([@bib2]), and then the Bioconductor package DESeq2 ([@bib46]) was used to normalize the raw counts, perform exploratory analysis (e.g., principal component analysis), and differential expression analysis. The Benjamini--Hochberg false discovery rate procedure was used to correct the p-values for multiple testing. Heat maps of the differentially expressed genes generated with the R package pheatmap ([@bib37]). UpSet plots were created with the R package UpSetR ([@bib16]), and the R implementation of Fisher's exact test, fisher.test, was used to identify enriched gene sets in the differentially expressed genes using the gene set collections from MSigDB ([@bib64])and the gene families from the Hugo Gene Nomenclature Committee ([@bib27]).

Statistical analyses {#s21}
--------------------

Statistical tests were performed using Prism (GraphPad) as described in the text and figure legends. In all figures, error bars represent mean ± SEM; \*, P ≤ 0.05; \*\*, P ≤ 0.01; \*\*\*, P ≤ 0.001.

Accession number {#s22}
----------------

All sequencing data has been uploaded to the GEO repository under accession no. [GSE107635](GSE107635).

Online supplemental material {#s23}
----------------------------

Fig. S1 shows labeling of macrophage populations with ZsGreen label 1 mo after tamoxifen induction in *Cx3cr1*^ERT2/+^:Ai6 mice at baseline and at the optic nerve crush site 3 d after optic nerve crush injury. Fig. S2 details loss of TMEM119 positivity in dLGN microglia postoptic nerve crush injury and localization of ingested CTB to the CD68+ phagolysosome. Quantification of GFAP+ cell number and engulfment as well as astrocyte phagocytosis measure by flow cytometry is also provided. Finally, RGC counts 3 d after optic nerve crush injury and RGCs counts and CTB field measurements 7 d after injury are also provided. Fig. S3 shows RGC counts in *Wld^S^* mice 3 d after optic nerve crush injury as well as pupil responses, RGC counts, and CTB field measurements in TTX-treated animals with optic nerve crush. Representative gating strategy, flow plots, and quantification of MACS efficiency for RNaseq of dLGN microglia are also shown along with changes in canonical microglial activation genes. Finally, RGC counts of *C1qa^−/−^* and *Itgam^−/−^* mice 3 d after injury are also provided.
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